Hee Gu Lee

USPTO Granted Patents = 9 (Patent Applications = 4)

EPO Patents = 2 (Patent Applications = 3)

Average Co-Inventor Count = 12.0

ph-index = 1

Forward Citations = 2(Granted Patents)

Company Filing History:

9 out of 321

Korea Research Institute of Bioscience and Biotechnology

where one patent can have more than one assignee

Years Active: 2010-2022

Loading Chart...

9 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 11446281 - Anti-inflammatory composition comprising acylhydrazone derivative (2022-09-20),

2. 9217149 - Pharmaceutical composition for treating cancer (2015-12-22),

3. 9075066 - CST1, DCC1, IFITM1 or MELK as markers for diagnosing stomach cancer (2015-07-07),

4. 9061022 - [object Object] (2015-06-23),

5. 9034327 - G protein coupled receptor protein and use thereof (2015-05-19),

6. 8846630 - Pharmaceutical composition for treating cancer (2014-09-30),

7. 8486905 - Use of FLJ25416 gene (2013-07-16),

8. 8283129 - Characterization of ESM-1 as a tumor associated marker of colorectal cancer (2012-10-09),

9. 7718780 - [object Object] (2010-05-18),

Title: Hee Gu Lee: Innovator in Pharmaceutical Composition

Introduction

Hee Gu Lee is a prominent inventor based in Daejeon, South Korea. He has made significant contributions to the field of pharmaceutical compositions, particularly in the treatment of inflammatory diseases and cancer. With a total of nine patents to his name, his work has the potential to impact the medical community significantly.

Latest Patents

One of Hee Gu Lee's latest patents is an anti-inflammatory composition comprising an acylhydrazone derivative. This invention relates to a composition designed to prevent, alleviate, or treat inflammatory diseases. The active ingredient effectively inhibits inflammatory cytokines and signaling pathways, thereby alleviating symptoms of conditions such as dermatitis. This composition holds promise for those suffering from inflammatory diseases.

Another notable patent is a pharmaceutical composition for treating cancer. This invention includes deoxyribonucleic acids (DNA) that encode small interfering RNA (siRNA) targeting the FLJ25416 gene. By inhibiting the expression of this gene, which is known to be present in cancer cells, the composition can potentially kill cancer cells. This innovative approach positions the composition as a novel anti-cancer agent.

Career Highlights

Hee Gu Lee has worked with esteemed organizations such as the Korea Research Institute of Bioscience and Biotechnology and St Pharm Co., Ltd. His experience in these institutions has allowed him to develop and refine his innovative ideas, contributing to his

This text is generated by artificial intelligence and may not be accurate.

Please report any incorrect information to support@idiyas.com

4 patents pending:

Please report any incorrect information to support@idiyas.com

2 patents (EPO):

Please report any incorrect information to support@idiyas.com

3 patents pending (EPO):

Please report any incorrect information to support@idiyas.com

Inventor’s Patent Attorneys refers to legal professionals with specialized expertise in representing inventors throughout the patent process. These attorneys assist inventors in navigating the complexities of patent law, including filing patent applications, conducting patent searches, and protecting intellectual property rights. They play a crucial role in helping inventors secure patents for their innovative creations.